Tag: function

Discover why the Matsato Knife is gaining global recognition in 2025. Explore expert insights, key features, and authentic user experiences behind this precision-crafted Japanese blade.

New York, The United States, July 02, 2025 (GLOBE NEWSWIRE) -- Zeagoo has officially launched its Prime Day event, unveiling some of the brand’s most compelling deals of the season. With discounts ranging from 10% to 40%, the sale spotlights a curated lineup of summer essentials crafted for comfort, versatility, and modern style. From effortlessly chic cotton shirt dresses to breathable gauze blouses and flattering swing silhouettes, each piece reflects Zeagoo’s signature blend of ease and elegance. Marketed under the campaign slogan “Prime Your Style. Be You,” the event showcases standout apparel designed to move seamlessly between daily wear and special moments—making this Prime Day not just about shopping, but upgrading your entire seasonal wardrobe.

In this 2025 public health alignment update, GlucoTru Pro emphasizes the growing consumer awareness of natural metabolic support strategies, including non-synthetic approaches to managing blood pressure, blood sugar, and overall wellness. This release provides new insights into public commentary themes, recent transparency in ingredient sourcing, and the alignment of the GlucoTru Pro formula with broader non-pharmaceutical health discussions.

WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the completion of the domestication process to change the jurisdiction of incorporation of the Company from the Cayman Islands to Delaware. The domestication was approved by shareholders of the Company at its Annual General Meeting held on May 29, 2025. Effective as of July 1, 2025, each (i) Class A ordinary share automatically converted into one share of Class A common stock of ProKidney Corp., a Delaware corporation and (ii) each Class B ordinary share automatically converted into one share of Class B common stock of ProKidney. ProKidney common stock will begin trading on July 2, 2025, and the Company's trading symbol on the Nasdaq Stock Market will remain unchanged as "PROK." The Company’s CUSIP number relating to its Class A common stock changed to 74291D 104. The Company does not anticipate any impact to day-to-day business operations as a result of the domestication.